News Focus
News Focus
icon url

Jimmy Quick

04/12/19 3:09 PM

#116265 RE: Spider Web #116259

I think that's considered marketing their CBD products. They have two lines of CBD products that they are using for topical lotions. I believe marketing their availability and uses as an alternative to opioids is considered good business practice to increase revenues and profits for all businesses in the retail field, not just pharmacy retail. Just saying. Lol. Seems pretty clear to me.

And for a company that this posts states is failing, they seem to be doing very well to me over the past several years. I will let the numbers speak for RXMD, not baseless opinions. Stock price going from $.005 to now over $.06 and as high as $.2659 kinda coincides with that growth and achievements, not failures.

OH MY, HOW RXMD HAS GROWN UP OVER THE YEARS


RXMD Revenues per location, Second to None


Penny Stock Exempt with low Share Structure


RXMD Compared to the Competition WOWSERS!!!


RXMD Retail Stores Commence Major Expansion Across Florida


RXMD 5 Star Humana Rating Earns Them Highest Payout


3 YEARS AUDITED F/S


Big Mistake Spot Last Year
Sell of shares at $.019


icon url

Wangenstein

04/12/19 3:43 PM

#116268 RE: Spider Web #116259

And I quote, from 11/25/2017:

TRIPLE - $0.005 - BOTTOM
-----------> Yup ! <-----------
* G U A R A N T E E D *


That didn't happen to RXMD. Neither will any of this.